Biogen
BIIB
BIIB
1,095 hedge funds and large institutions have $45.8B invested in Biogen in 2020 Q1 according to their latest regulatory filings, with 112 funds opening new positions, 325 increasing their positions, 473 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,095
Holders Change
-4
Holders Change %
-0.36%
% of All Funds
24.19%
Holding in Top 10
49
Holding in Top 10 Change
+18
Holding in Top 10 Change %
+58.06%
% of All Funds
1.08%
New
112
Increased
325
Reduced
473
Closed
101
Calls
$1.24B
Puts
$1.51B
Net Calls
-$271M
Net Calls Change
+$283M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$1.36B |
| 2 |
Primecap Management
Pasadena,
California
|
$5.05B |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
$692M |
| 4 |
O
OrbiMed
New York
|
$152M |
| 5 |
BlackRock
New York
|
$5.08B |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
$132M |
| 2 |
Capital World Investors
Los Angeles,
California
|
$227M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
$107M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
$458M |
| 5 |
ClearBridge Investments
New York
|
$1.39B |
